Internal Medicine, Hematology & Oncology · Riverside, CA
NPI
1386703031
Since 2006
Specialty
Internal Medicine, Hematology & Oncology
Code 207RH0003X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
10800 Magnolia Ave
Riverside, CA, 92505
Phone (909) 353-2000
Groups this clinician bills Medicare through
Medicare paid, 2024
$26K
1,737 services
Medicare patients, 2024
20
Average age 63
Drug cost, 2024
$5.3M
1,781 prescriptions
Company payments, 2025
$5,173
From 9 companies
Medicare prescription drug claims, 2024
In 2024, the drug Andy S Jang prescribed most often to Medicare patients was Abiraterone Acetate, with 167 prescriptions and refills. In total Andy S Jang wrote 1,781 Medicare prescriptions that cost $5.3M.
| Drug |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2021-12-22.
| Claims |
|---|
| 30-day fills |
|---|
| Patients |
|---|
| Cost |
|---|
| Abiraterone Acetate Generic | 167 | 170 | 25 | $25K |
| Prednisone Generic | 156 | 225 | 37 | $1,396 |
| Anastrozole Generic | 131 | 386 | 43 | $3,612 |
| Lenalidomide Generic | 92 | 92 | 14 | $1.1M |
| Dexamethasone Generic | 89 | 122 | 21 | $1,655 |
| Ondansetron Hcl Generic | 70 | 70 | 32 | $577 |
| Morphine Sulfate Er Morphine Sulfate | 64 | 64 | 11 | $2,613 |
| Pradaxa Dabigatran Etexilate Mesylate | 64 | 88 | 14 | $8,875 |
| Tamoxifen Citrate Generic | 46 | 136 | 20 | $1,421 |
| Levothyroxine Sodium Generic | 43 | 101 | 11 | $657 |
| Acyclovir Generic | 39 | 82 | 11 | $890 |
| Tagrisso Osimertinib Mesylate | 39 | 39 | Under 11 | $687K |
| Hydroxyurea Generic | 37 | 73 | Under 11 | $1,054 |
| Imatinib Mesylate Generic | 35 | 39 | Under 11 | $2,079 |
| Hydromorphone Hcl Generic | 34 | 34 | Under 11 | $1,024 |
Brand drugs: 422 claims; generic drugs: 1,347 claims; opioid claims: 144.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Andy S Jang $5,173 ($5,173 in general payments such as food, travel and fees) from 9 companies. The largest payer was Syndax Pharmaceuticals, Inc. with $3,946.
| Company | Payments | Amount |
|---|---|---|
| Syndax Pharmaceuticals, Inc. SNDX | 10 | $3,946 |
| Daiichi Sankyo Inc. 4568.T | 1 | $650 |
| E.R. Squibb & Sons, L.L.C. BMY | 1 | $130 |
| AstraZeneca Pharmaceuticals LP AZN | 2 | $124 |
| Genentech, Inc. ROG.SW | 1 | $107 |
| Incyte Corporation INCY | 1 | $96.66 |
| Immunocore Limited IMCR | 1 | $54.53 |
| Kite Pharma, Inc. GILD | 1 | $39.59 |
| Pfizer Inc. PFE | 1 | $25.3 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.